1 – 10 of 34
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
- 
                        Mark
        Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma Subtypes
    
    - Contribution to journal › Article
 
- 
                        Mark
        Machine Learning-enhanced X-ray-based Radiomics in the Identification of Post-COVID Patients
    
    - Contribution to journal › Article
 
- 
                        Mark
        TMEM160 Promotes Tumor Growth in Lung Adenocarcinoma and Cervical Adenocarcinoma Cell Lines
    
    - Contribution to journal › Article
 
- 
                        Mark
        Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies
    
    - Contribution to journal › Article
 
- 
                        Mark
        Melanoma Proteomics Unveiled : Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT
    
    - Contribution to journal › Article
 
- 
                        Mark
        Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma
    
    - Contribution to journal › Article
 
- 
                        Mark
        Expanding the landscape of lysine acetylation stoichiometry and clinical impact
    
    - Contribution to journal › Scientific review
 
- 
                        Mark
        KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer’s disease
    
    - Contribution to journal › Article
 
- 2024
- 
                        Mark
        Dynamics of Mitochondrial Proteome and Acetylome in Glioblastoma Cells with Contrasting Metabolic Phenotypes
    
    - Contribution to journal › Article
 
- 
                        Mark
        Identification of genetic fingerprint of type I interferon therapy in visceral metastases of melanoma
    
    - Contribution to journal › Article
 
